ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $761,576 | +11.4% | 28,343 | +47.8% | 0.00% | 0.0% |
| Q2 2023 | $683,816 | +31.1% | 19,176 | -6.7% | 0.00% | – |
| Q1 2023 | $521,792 | -30.3% | 20,543 | +11.3% | 0.00% | -100.0% |
| Q4 2022 | $748,494 | +62.4% | 18,454 | +32.2% | 0.00% | – |
| Q3 2022 | $461,000 | -8.0% | 13,957 | -1.9% | 0.00% | – |
| Q2 2022 | $501,000 | -23.5% | 14,225 | -0.0% | 0.00% | -100.0% |
| Q1 2022 | $655,000 | -31.6% | 14,232 | -1.4% | 0.00% | 0.0% |
| Q4 2021 | $957,000 | +5.5% | 14,439 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $907,000 | -17.7% | 14,521 | +9.2% | 0.00% | 0.0% |
| Q2 2021 | $1,102,000 | +16.5% | 13,303 | -6.8% | 0.00% | 0.0% |
| Q1 2021 | $946,000 | -25.0% | 14,272 | -13.2% | 0.00% | 0.0% |
| Q4 2020 | $1,261,000 | +63.6% | 16,434 | -8.2% | 0.00% | 0.0% |
| Q3 2020 | $771,000 | -52.3% | 17,896 | -52.2% | 0.00% | -50.0% |
| Q2 2020 | $1,616,000 | +139.1% | 37,406 | +59.2% | 0.00% | +100.0% |
| Q1 2020 | $676,000 | -38.4% | 23,497 | +35.9% | 0.00% | 0.0% |
| Q4 2019 | $1,097,000 | +347.8% | 17,288 | +98.6% | 0.00% | – |
| Q3 2019 | $245,000 | +345.5% | 8,707 | -15.2% | 0.00% | – |
| Q2 2016 | $55,000 | – | 10,263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |